CHPA To Lobby Against FDA-Initiated Rx-To-OTC Switches
This article was originally published in The Tan Sheet
Executive Summary
Congress should discourage FDA from pursuing Rx-to-OTC switches without the drug sponsor's approval, the Consumer Healthcare Products Association asserts